In parallel, the pandemic has underscored the role of a dysregulated immune response, known as cytokine release syndrome (CRS), characterized by the overproduction of inflammatory cytokines like TNF-α, IL-6, IL-1β, and IFN-γ, which serve as inflammatory biomarkers of COVID-19. This evidence concerns the gene IL6 and congenital rubella syndrome.